Recital 58, Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

In forcesince 22 May 2012

A level playing field should be established as quickly as possible on the market for existing active substances, taking into account the objectives of reducing unnecessary tests and costs to the minimum, in particular for SMEs, of avoiding the establishment of monopolies, of sustaining free competition between economic operators and of equitable compensation of the costs borne by data owners.